二甲双胍联合地屈孕酮治疗多囊卵巢综合征的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Metformin as adjuvant therapy for treatment of patients with polycystic ovary syndrome (PCOS).Methods Thirty patients with PCOS who came to our hospital from March 2015 to June 2017 were selected as subjects of study.They were divided into control group and study group according to the random number table method,15 cases in each group.The control group was treated with Dydrogesterone,while the study group was added with Metformin besides Dydrogesterone.The clinical efficacy,tumor necrosis factor-α (TNF-α),homeostasis model assessment-insulin resistance (HOMA-IR),serum estradiol (E2),follicle stimulating hormone (FSH),testosterone(T),luteinizing hormone(LH),and the occurrence of adverse reactions were compared between the two groups.Results The clinical effective rate of the study group was 93.33%,higher than that of the control group accounting for 60.00%，the difference was statistically significant (P＜0.05).There were no significant differences in HOMA-IR,TNFα,LH,FSH,T and E2 levels between the two groups before intervention (P＞0.05).After intervention,HOMA-IR,TNFα,LH,FSH,T,and E2 level were lower than those before the intervention,and those indexes in study group were lower than those of the control group，the differences were statistically significant (P＜0.05).There was no significant difference in the incidence of adverse reactions between the study group (13.33%) and the control group (20.00%) (P＞0.05).Conclusion Metformin is effective in the treatment of PCOS with Dexamethasone,which can improve IR,inflammatory status and endocrine metabolism in patients.

Key words： Polycystic ovary syndrome Insulin resistance Metformin Dydrogesterone Endocrine metabolism

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHONG Xiu-chang

Cite this article:

ZHONG Xiu-chang. Clinical effect of Metformin combined with Dydrogesterone in the treatment of polycystic ovary syndrome[J]. 中国当代医药, 2020, 27(5): 137-139.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I5/137

[1]	杨志平.达英-35联合二甲双胍治疗多囊卵巢综合征对激素、胰岛素抵抗的影响[J].中国妇幼保健，2016，31（5）：1015-1017.
[2]	宋霁，肖国宏，杨洁，等.二甲双胍对多囊卵巢综合征患者颗粒细胞的作用[J].广东医学，2016，37（10）：1567-1570.
[3]	郝翠云.达英-35和二甲双胍对多囊卵巢综合征不孕患者性激素水平及胰岛素抵抗的影响[J].中国医药导报，2016，13（9）：128-130.
[4]	徐岚，熊煜.炔雌醇环丙孕酮联合二甲双胍对多囊卵巢综合征患者排卵的影响[J].中国药房，2016，27（24）：3368-3370.
[5]	覃庆媛，贺青蓉，叶焕巧，等.达英-35联合二甲双胍治疗多囊卵巢综合征不孕的疗效及其对患者内分泌性激素和代谢的影响[J].海南医学，2017，28（1）：70-72.
[6]	李宇称，彭琦琳，彭惠文.达英-35联合二甲双胍治疗多囊卵巢综合征后促排卵效果分析[J].数理医药学杂志，2016，29（11）：1669-1670.
[7]	宋艳华，廖英，夏亦冬.益肾化痰方联合二甲双胍治疗多囊卵巢综合征合并胰岛素抵抗的临床评价[J].上海中医药大学学报，2016，30（3）：35-38.
[8]	吕昕瞳.自拟补肾活血方剂联合炔雌醇环丙孕酮片及二甲双胍治疗多囊卵巢综合征疗效及对内分泌代谢和排卵的影响[J].现代中西医结合杂志，2017，26（5）：508-510.
[9]	王斌，黄芳，欧丽红.屈螺酮炔雌醇片联合二甲双胍治疗多囊卵巢综合征的疗效及预后分析[J].现代诊断与治疗，2016，27（1）：60-61.
[10]	张喜梅，马国芳.克罗米芬联合二甲双胍对多囊卵巢综合征患者外周血T细胞亚群及氧化应激水平的影响[J].山东医药，2017，57（12）：88-90.
[11]	吴茜二甲双胍在多囊卵巢综合征中应用的研究进展[J].浙江医学，2016，38（9）：671-674.
[12]	黎艳，付丽，王慧英，等.克罗米酚联合二甲双胍对多囊卵巢综合征患者促进排卵疗效观察及对血清性激素结合球蛋白与硫酸脱氢表雄酮的影响[J].中国妇幼保健，2016，31（2）：418-420.
[13]	刘玉婷，刘东方，杨刚毅，等.二甲双胍治疗多囊卵巢综合征的临床效果[J].中国当代医药，2017，24（32）：46-49.
[14]	刘玲，赵恒侠，李惠林，等.荷芪散联合二甲双胍治疗多囊卵巢综合征伴胰岛素抵抗的临床研究[J].世界中医药，2017，12（8）：1832-1835.
[15]	赵松青，方成霞，刘正华，等.炔雌醇环丙孕酮联合二甲双胍对多囊卵巢综合征患者内分泌及糖脂代谢的影响[J].徐州医学院学报，2016，36（9）：578-581.